| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
ATP binding cassette subfamily B member 1 | 0.344 | 0.885 | 1.3E-05 |
|
phenotype | 0.100 | None | 1.000 | 15 | 0 | 1993 | 2020 | ||||||||
|
interleukin 2 | 0.336 | 0.885 | 0.48 |
|
phenotype | 0.100 | None | 1.000 | 14 | 0 | 1994 | 2019 | ||||||||
|
enhancer of zeste 2 polycomb repressive complex 2 subunit | 0.376 | 0.885 | 1.00 |
|
phenotype | 0.400 | None | 1.000 | 13 | 0 | 2008 | 2019 | ||||||||
|
microRNA 21 | 0.363 | 0.846 |
|
phenotype | 0.100 | None | 1.000 | 13 | 0 | 2009 | 2019 | |||||||||
|
neurotrophic receptor tyrosine kinase 1 | 0.422 | 0.808 | 2.0E-06 |
|
phenotype | 0.100 | None | 1.000 | 13 | 0 | 2001 | 2020 | ||||||||
|
tumor necrosis factor | 0.231 | 0.962 | 0.80 |
|
phenotype | 0.100 | None | 1.000 | 13 | 0 | 2004 | 2019 | ||||||||
|
CEA cell adhesion molecule 5 | 0.420 | 0.846 | 4.2E-10 |
|
phenotype | 0.100 | None | 0.917 | 12 | 0 | 1995 | 2019 | ||||||||
|
KIT proto-oncogene, receptor tyrosine kinase | 0.366 | 0.808 | 0.98 |
|
phenotype | 0.100 | None | 1.000 | 12 | 0 | 1992 | 2018 | ||||||||
|
cyclin dependent kinase inhibitor 2A | 0.300 | 0.885 | 0.39 |
|
phenotype | 0.100 | None | 1.000 | 11 | 1 | 1995 | 2017 | ||||||||
|
poly(ADP-ribose) polymerase 1 | 0.389 | 0.923 | 3.3E-04 |
|
phenotype | 0.100 | None | 1.000 | 11 | 0 | 2015 | 2020 | ||||||||
|
epidermal growth factor | 0.357 | 0.923 | 8.5E-17 |
|
phenotype | 0.100 | None | 1.000 | 11 | 0 | 1997 | 2018 | ||||||||
|
folate hydrolase 1 | 0.453 | 0.885 | 6.2E-09 |
|
phenotype | 0.100 | None | 1.000 | 11 | 0 | 2003 | 2019 | ||||||||
|
isocitrate dehydrogenase (NADP(+)) 1 | 0.424 | 0.808 | 2.6E-12 |
|
phenotype | 0.100 | None | 1.000 | 11 | 0 | 2009 | 2020 | ||||||||
|
programmed cell death 1 | 0.402 | 0.846 | 0.42 |
|
phenotype | 0.100 | None | 1.000 | 11 | 0 | 2017 | 2020 | ||||||||
|
collagen type XVIII alpha 1 chain | 0.449 | 0.808 | 1.7E-10 |
|
phenotype | 0.100 | None | 0.909 | 11 | 0 | 2000 | 2017 | ||||||||
|
CD19 molecule | 0.430 | 0.885 | 0.90 |
|
phenotype | 0.100 | None | 1.000 | 11 | 0 | 2014 | 2019 | ||||||||
|
cytotoxic T-lymphocyte associated protein 4 | 0.369 | 0.923 | 0.94 |
|
phenotype | 0.090 | None | 1.000 | 9 | 0 | 2012 | 2019 | ||||||||
|
ALK receptor tyrosine kinase | 0.396 | 0.846 | 3.2E-06 |
|
phenotype | 0.090 | None | 1.000 | 9 | 0 | 2008 | 2019 | ||||||||
|
KRAS proto-oncogene, GTPase | 0.320 | 0.923 | 7.9E-04 |
|
phenotype | 0.090 | None | 1.000 | 9 | 0 | 2009 | 2019 | ||||||||
|
WT1 transcription factor | 0.422 | 0.808 | 1.00 |
|
phenotype | 0.090 | None | 1.000 | 9 | 0 | 1999 | 2019 | ||||||||
|
CD44 molecule (Indian blood group) | 0.363 | 0.962 | 2.4E-07 |
|
phenotype | 0.090 | None | 1.000 | 9 | 0 | 1993 | 2018 | ||||||||
|
eukaryotic translation initiation factor 4E | 0.448 | 0.846 | 0.94 |
|
phenotype | 0.080 | None | 1.000 | 8 | 0 | 1999 | 2017 | ||||||||
|
erb-b2 receptor tyrosine kinase 3 | 0.448 | 0.808 | 1.7E-15 |
|
phenotype | 0.080 | None | 1.000 | 8 | 0 | 2015 | 2020 | ||||||||
|
MCL1 apoptosis regulator, BCL2 family member | 0.430 | 0.808 | 0.96 |
|
phenotype | 0.080 | None | 1.000 | 8 | 0 | 1994 | 2019 | ||||||||
|
MDM2 proto-oncogene | 0.362 | 0.846 | 1.00 |
|
phenotype | 0.080 | None | 1.000 | 8 | 1 | 1993 | 2019 |